The Epstein-Barr virus and a high-risk gene may work together to trick the immune system into attacking the brain in MS, a study suggests.
A newly identified mechanism lends credence to the idea that MS may be treatable by targeting EBV-infected B-cells, a study found.
News-Medical.Net on MSN
Epstein-Barr virus together with a gene variant contributes to onset of multiple sclerosis
One of the leading triggers for multiple sclerosis (MS) is an infection with the Epstein-Barr virus. However, certain gene variants also play an important role. Researchers at the University of Zurich ...
A study published in Nature looks at genetic determinants of persistent Epstein-Barr virus DNA and associations with chronic conditions. Prof Lawrence Young, Virologist and Emeritus Professor of ...
Tabelecleucel BLA currently under U.S. Food and Drug Administration (FDA) Priority Review as potentially the first approved therapy in the U.S. for EBV+ PTLD with a Prescription Drug User Fee Act ...
Please provide your email address to receive an email when new articles are posted on . Epstein-Barr virus activates certain B cells involved in systemic lupus erythematosus disease pathogenesis. The ...
The FDA issued a second Complete Response Letter for tabelecleucel, citing concerns over trial design and data interpretability in EBV+ PTLD.
When people ask their doctors about lupus causes, their answer can sometimes sound frustratingly vague. While they know that genetics plays a role, as do hormones and the environment, specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results